Brian Lian
CIK 1614578 · President & CEO · last filed 2026-01-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$78.57M
Companies
3
Total Filings
42
Lifetime Open-Market Net
-$69.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VKTX | President & CEO | 2,732,700 | $28.75 | $78.57M | -$69.71M | 26 | 2026-01-05 |
| SEELOS THERAPEUTICS, INC. (SEEL) Delisted | Director | — | $0.39 | — | $0 | 6 | 2024-01-08 |
| Viking Therapeutics, Inc. (VKTXW) Delisted | President & CEO | 1,894,181 | $4.60 | $8.71M | $0 | 10 | 2021-01-19 |
Recent Filings · Page 4 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-21 | Viking Therapeutics, Inc. (VKTXW) Delisted | Tax (F) | −3,195 | -$22.9K | EDGAR |
| 2020-01-07 | SEELOS THERAPEUTICS, INC. (SEEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | Viking Therapeutics, Inc. (VKTXW) Delisted | Mixed | +146,551 | -$52.7K | EDGAR |
| 2019-03-21 | SEELOS THERAPEUTICS, INC. (SEEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-22 | Viking Therapeutics, Inc. (VKTXW) Delisted | Tax (F) | −4,333 | -$38.0K | EDGAR |
| 2019-01-03 | Viking Therapeutics, Inc. (VKTXW) Delisted | Grant (A) | +80,897 | $0 | EDGAR |
| 2018-05-08 | Viking Therapeutics, Inc. (VKTXW) Delisted | Tax (F) | −10,086 | -$42.6K | EDGAR |
| 2018-01-23 | Viking Therapeutics, Inc. (VKTXW) Delisted | Grant (A) | +40,000 | $0 | EDGAR |
| 2017-01-05 | Viking Therapeutics, Inc. (VKTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-15 | VKTX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.